Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study

BACKGROUND: Interleukin-6 (IL-6) was proposed to be associated with the severity of coronavirus disease 2019 (COVID-19). The present study aimed to explore the kinetics of IL-6 levels, validate this association in COVID-19 patients, and report preliminary data on the efficacy of IL-6 receptor blocka...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Hao, Yiqun, Ou, Wuling, Ming, Fei, Liang, Gai, Qian, Yu, Cai, Qian, Dong, Shuang, Hu, Sheng, Wang, Weida, Wei, Shaozhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594951/
https://www.ncbi.nlm.nih.gov/pubmed/33121497
http://dx.doi.org/10.1186/s12967-020-02571-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594951/
https://www.ncbi.nlm.nih.gov/pubmed/33121497
http://dx.doi.org/10.1186/s12967-020-02571-x

Ejemplares similares